M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Other Equity Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Other Equity
$2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Other Equity
-$93k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Other Equity
-CHf35k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Other Equity
$10.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Other Equity?
Other Equity
2.4m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Other Equity amounts to 2.4m USD.

What is MoonLake Immunotherapeutics's Other Equity growth rate?
Other Equity CAGR 1Y
574%

Over the last year, the Other Equity growth was 574%.

Back to Top